Keyphrases
Cancer Institute
100%
Penn State
100%
Memorial Sloan-Kettering Cancer Center
66%
Maximum Tolerated Dose
50%
MSKCC
33%
Ceramide Nanoliposome
25%
Specific Intent
25%
Animal Modeling
25%
Therapeutic Study
25%
Dose Escalation
25%
Pharmacokinetic Evaluation
25%
Molecular Characteristics
25%
Clinical Characteristics
25%
Preclinical Data
25%
Preclinical Efficacy
25%
Testing Program
25%
Clinical Material
25%
Clinical Resources
25%
PDX Model
25%
Art Resources
25%
Pharmacokinetics
25%
Efficacy Data
25%
State-of-the-art Models
25%
Morphological Characteristics
25%
Ara-C
25%
Therapeutic Regimen
25%
Mechanism-based
25%
Luciferase
25%
Tissue Bank
25%
Transplantable
25%
Chemotherapy Regimen
25%
Neoplasms
25%
Sphingolipid Metabolism
25%
Well-defined
25%
Xenograft
25%
Venetoclax
25%
Dose Assessment
25%
Clinically Significant
25%
Clinical Development
25%
In Vitro Study
25%
AML Cells
25%
Standard-of-care Chemotherapies
25%
Leukemia
16%
Clinical Trials
16%
Ethics Review Committees
16%
Cell Line Models
16%
Cancer Center
8%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Neoplasm
30%
Maximum Tolerated Dose
30%
Clinical Trial
23%
Ceramide
15%
Venetoclax
15%
Sphingolipid
15%
Luciferase
15%
Clinical Study
15%
Chemotherapy
15%
Dose Toxicity
15%
Liposome
15%
Leukemia
8%
Biological Product
6%